124 related articles for article (PubMed ID: 38056490)
1. Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas.
Iglesias P; Biagetti B; Araujo-Castro M; Alcázar V; Guerrero-Pérez F; Rivero N; Casteràs A; Gómez CG; Izquierdo BG; Torres VV; Pascual-Corrales E; Pavón I; Villabona C; Cordido F; Díez JJ
Exp Clin Endocrinol Diabetes; 2023 Dec; 131(12):631-638. PubMed ID: 38056490
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
3. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.
Potorac I; Petrossians P; Daly AF; Schillo F; Ben Slama C; Nagi S; Sahnoun M; Brue T; Girard N; Chanson P; Nasser G; Caron P; Bonneville F; Raverot G; Lapras V; Cotton F; Delemer B; Higel B; Boulin A; Gaillard S; Luca F; Goichot B; Dietemann JL; Beckers A; Bonneville JF
Endocr Relat Cancer; 2015 Apr; 22(2):169-77. PubMed ID: 25556181
[TBL] [Abstract][Full Text] [Related]
4. Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly.
Heck A; Ringstad G; Fougner SL; Casar-Borota O; Nome T; Ramm-Pettersen J; Bollerslev J
Clin Endocrinol (Oxf); 2012 Jul; 77(1):72-8. PubMed ID: 22066905
[TBL] [Abstract][Full Text] [Related]
5. Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas.
Tortora F; Negro A; Grasso LFS; Colao A; Pivonello R; Splendiani A; Brunese L; Caranci F
Gland Surg; 2019 Sep; 8(Suppl 3):S150-S158. PubMed ID: 31559182
[TBL] [Abstract][Full Text] [Related]
6. T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly.
Akkaya E; Akgun MY; Sebnem Durmaz E; Aydın S; Mefkure Ozkaya H; Comunoglu N; Kizilkilic O; Gazioglu N; Kadioglu P; Tanriover N
J Clin Neurosci; 2021 Aug; 90():105-111. PubMed ID: 34275532
[TBL] [Abstract][Full Text] [Related]
7. Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.
Liu CX; Wang SZ; Heng LJ; Han Y; Ma YH; Yan LF; Yu Y; Wang W; Hu YC; Cui GB
J Comput Assist Tomogr; 2022 Jan-Feb 01; 46(1):124-130. PubMed ID: 35099144
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas.
Kasuki L; Antunes X; Coelho MCA; Lamback EB; Galvão S; Silva Camacho AH; Chimelli L; Ventura N; Gadelha MR
Clin Endocrinol (Oxf); 2020 Feb; 92(2):145-149. PubMed ID: 31773787
[TBL] [Abstract][Full Text] [Related]
9. T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective.
Potorac I; Beckers A; Bonneville JF
Pituitary; 2017 Feb; 20(1):116-120. PubMed ID: 28197813
[TBL] [Abstract][Full Text] [Related]
10. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.
Heck A; Emblem KE; Casar-Borota O; Bollerslev J; Ringstad G
Endocrine; 2016 May; 52(2):333-43. PubMed ID: 26475495
[TBL] [Abstract][Full Text] [Related]
12. T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.
Burlacu MC; Maiter D; Duprez T; Delgrange E
Endocrine; 2019 Feb; 63(2):323-331. PubMed ID: 30267354
[TBL] [Abstract][Full Text] [Related]
13. Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.
Alhambra-Expósito MR; Ibáñez-Costa A; Moreno-Moreno P; Rivero-Cortés E; Vázquez-Borrego MC; Blanco-Acevedo C; Toledano-Delgado Á; Lombardo-Galera MS; Vallejo-Casas JA; Gahete MD; Castaño JP; Gálvez MA; Luque RM
Sci Rep; 2018 Apr; 8(1):6173. PubMed ID: 29670116
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.
Zhang S; Song G; Zang Y; Jia J; Wang C; Li C; Tian J; Dong D; Zhang Y
Eur Radiol; 2018 Sep; 28(9):3692-3701. PubMed ID: 29572634
[TBL] [Abstract][Full Text] [Related]
15. Sphenoid sinus ectopic pituitary adenomas: CT and MRI findings.
Yang BT; Chong VF; Wang ZC; Xian JF; Chen QH
Br J Radiol; 2010 Mar; 83(987):218-24. PubMed ID: 19651706
[TBL] [Abstract][Full Text] [Related]
16. Nonfunctioning pituitary adenomas in pediatric and adolescent patients: a clinical analysis of a series of 14 patients.
Wang H; Wang R; Hu T; Wang Z; Duan Y; Han S; Wu A
J Neurooncol; 2020 May; 148(1):179-186. PubMed ID: 32333187
[TBL] [Abstract][Full Text] [Related]
17. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenoma consistency: Direct correlation of ultrahigh field 7T MRI with histopathological analysis.
Yao A; Rutland JW; Verma G; Banihashemi A; Padormo F; Tsankova NM; Delman BN; Shrivastava RK; Balchandani P
Eur J Radiol; 2020 May; 126():108931. PubMed ID: 32146344
[TBL] [Abstract][Full Text] [Related]
19. Additional Diagnostic Value of Unenhanced Computed Tomography plus Diffusion-Weighted Imaging Combined with Routine Magnetic Resonance Imaging Findings of Early-Stage Gliblastoma.
Wang H; Liu Z; Zhang Y; Hou F; Fu W; Lin J; Liu Y; Liu X
Biomed Res Int; 2020; 2020():1672736. PubMed ID: 32149081
[TBL] [Abstract][Full Text] [Related]
20. Atypical pituitary adenoma: a clinicopathologic case series.
Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
